NICE Ltd. (TLV:NICE)
Israel · Delayed Price · Currency is ILS · Price in ILA | Market Cap | 18.47B -29.8% |
| Revenue (ttm) | 9.59B +8.6% |
| Net Income | 1.15B -33.0% |
| EPS | 19.08 -29.2% |
| Shares Out | 58.60M |
| PE Ratio | 16.52 |
| Forward PE | 7.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 106,407 |
| Open | 31,580 |
| Previous Close | 31,580 |
| Day's Range | 30,790 - 31,750 |
| 52-Week Range | 24,260 - 45,740 |
| Beta | 0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About NICE Ltd.
NICE Ltd., together with its subsidiaries, provides AI-powered cloud platforms for customer engagement, and financial crime and compliance in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Customer Engagement; and Financial Crime and Compliance. The Customer Engagement segment provides CXone Mpower platform for organizations to automate service, augment the workforce with AI-powered solutions, and unify enterprise knowledge, data and AI models resolutions, and customer experiences. The Fin... [Read more]
Financial Performance
In 2025, NICE Ltd.'s revenue was $2.95 billion, an increase of 7.68% compared to the previous year's $2.74 billion. Earnings were $612.10 million, an increase of 38.30%.
Financial numbers in USD Financial StatementsNews
Nice price target raised to $115 from $111 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Nice (NICE) to $115 from $111 and keeps an Equal Weight rating on the shares. Nice’s AI demand indicators remain healthy, but…
Nice price target lowered to $120 from $130 at Mizuho
Mizuho lowered the firm’s price target on Nice (NICE) to $120 from $130 and keeps an Outperform rating on the shares.
Nice price target lowered to $130 from $145 at RBC Capital
RBC Capital analyst Rishi Jaluria lowered the firm’s price target on Nice (NICE) to $130 from $145 and keeps an Outperform rating on the shares. The company reported mixed Q3…
Nice price target lowered to $158 from $170 at Citizens
Citizens lowered the firm’s price target on Nice (NICE) to $158 from $170 and keeps an Outperform rating on the shares. The company reported mixed Q3 results and guidance, the…
NICE Ltd. Reports 8% Year-Over-Year Revenue Growth in Third Quarter 2026
NICE Ltd. reported total revenue of $790.7 million for the third quarter ended September 30, 2026, representing an increase of 8.0% compared to $732.0 million in the third quarter of 2025. Cloud reven...
NiCE Q3 Earnings Call Highlights
NiCE NASDAQ: NICE reported third-quarter revenue and adjusted earnings above the high end of its guidance, while management said it is taking steps to improve cloud growth and streamline operations th...
NiCE Q3 Earnings Call Highlights
3 Beaten-Down Stocks With Rebound Potential This Earnings SeasonNiCE (NASDAQ:NICE) reported third-quarter revenue and adjusted earnings above the high end of its guidance, while management said it is ...
NICE Ltd. Earnings Call Transcript: Q3 2026
Q3 revenue and adjusted EPS exceeded guidance, but cloud growth remained a focus amid slower AI ramps and softness in non-core streams. FY26 EPS guidance rose, while management maintained confidence in longer-term cloud acceleration.
NICE Ltd. Earnings release: Q3 2026
NICE Ltd. released its Q3 2026 earnings on November 4, 2026, summarizing the period's financial results.
NICE Ltd. Slides: Q3 2026
NICE Ltd. has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 4, 2026.
NICE Ltd. Q3 26 Earnings Conference Call At 8:30 AM ET
(RTTNews) - NICE Ltd. (NICE) will host a conference call at 8:30 AM ET on November 4, 2026 to discuss Q3 26 earnings results.
NiCE Boosts FY26 Adj. EPS Outlook; To Cut 5% Workforce - Update
(RTTNews) - While reporting financial results for the third quarter on Wednesday, NiCE Ltd. (NICE) raised its adjusted earnings guidance for the full-year 2026, while reiterating annual adjusted reven...
Nice to reduce global workforce by 5%
NiCE (NICE) is streamlining its organization, reducing management layers and simplifying decision-making, while strengthening its partner-led go-to-market and delivery capabilities. As part of this ef...
NICE Ltd. Q3 Profit Declines
(RTTNews) - NICE Ltd. (NICE) released earnings for third quarter that Drops, from last year
NiCE Exceeds Revenue and EPS Guidance Ranges, Reporting 8% Year-Over-Year Revenue Growth in Third Quarter 2026
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (NASDAQ: NICE) today announced results for the third quarter ended September 30, 2026, as compared to the corresponding period of the previous year. Third Quarter ...
NiCE Provides Webcast and Dial-in Details for its Third Quarter 2026 Results Teleconference
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) will announce its third quarter 2026 results on Wednesday, November 4, 2026, before the opening of the NASDAQ Stock Exchange. Later that day, manage...
NiCE Named a Leader in the 2026 Gartner® Magic Quadrant™ for Contact Center as a Service. Delivering AI-Powered Customer Service at Enterprise Scale
HOBOKEN, N.J.--(BUSINESS WIRE)-- #AI--NiCE (Nasdaq: NICE) today announced it has been named a Leader in the 2026 Gartner Magic Quadrant for Contact Center as a Service (CCaaS). NiCE was placed furthes...
NICE Stock Analysis: Buy or Sell?
Investors are curious if this is a value stock or a value trap.
NiCE Names Carahsoft Distributor of the Year for 2025
Company Recognized for Connecting Public Sector Organizations With AI-Powered Customer Service Solutions Company Recognized for Connecting Public Sector Organizations With AI-Powered Customer Service ...
NiCE Named a Leader in the IDC MarketScape for Worldwide Agentic Contact Center-as-a-Service Platforms
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) today announced it has been positioned in the Leaders category in the IDC MarketScape: Worldwide Agentic Contact Center–as-a-Service Platforms 2026 ...
NICE issues final draft guidance recommending ▼ Tryngolza® (olezarsen) as an option to treat genetically confirmed familial chylomicronaemia syndrome (FCS) in adults in England and Wales
CAMBRIDGE, England--(BUSINESS WIRE)--FOR UK HEALTHCARE/TRADE MEDIA ONLY Sobi® UK today announced that the National Institute for Health and Care Excellence (NICE) has issued final draft guidance which...
Oppenheimer upgrades Nice as AI disruption fears ease, platform improves
As previously reported, Oppenheimer upgraded Nice (NICE) to Outperform from Perform with a $150 price target The firm cites the company’s improved AI platform, increasing demand from AI agents and…
Nice upgraded to Outperform from Perform at Oppenheimer
Oppenheimer analyst Timothy Horan upgraded Nice (NICE) to Outperform from Perform with a $150 price target
NiCE Named a 2026 Best Workplace for Innovators by Fast Company in the Cybersecurity & Enterprise Category
HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (Nasdaq: NICE) today announced that it has been named a 2026 Best Workplace for Innovators by Fast Company in the Cybersecurity & Enterprise Category, recognizing ...
Nice price target raised to $145 from $130 at RBC Capital
RBC Capital raised the firm’s price target on Nice (NICE) to $145 from $130 and keeps an Outperform rating on the shares after hosting its management team for investor meetings.